Voya Investment Management LLC Cel Sci Corp Transaction History

Voya Investment Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.58 - $4.99 $35,735 - $69,116	-13,851 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$7.1 - $12.82 $4,764 - $8,602	-671 Reduced 4.62%	13,851 $98,000
Q2 2021 Aug 16, 2021	SELL	$8.68 - $27.49 $10,199 - $32,300	-1,175 Reduced 7.49%	14,522 $126,000
Q1 2021 May 17, 2021	BUY	$12.0 - $27.64 $4,668 - $10,751	389 Added 2.54%	15,697 $239,000
Q4 2020 Feb 16, 2021	BUY	$11.05 - $16.62 $43,846 - $65,948	3,968 Added 34.99%	15,308 $178,000
Q2 2020 Aug 14, 2020	SELL	$9.75 - $17.6 $53,205 - $96,043	-5,457 Reduced 32.49%	11,340 $169,000
Q1 2020 May 15, 2020	BUY	$7.54 - $17.05 $20,109 - $45,472	2,667 Added 18.87%	16,797 $194,000
Q4 2019 Feb 14, 2020	BUY	$6.71 - $9.55 $23,941 - $34,074	3,568 Added 33.78%	14,130 $129,000
Q2 2019 Aug 14, 2019	BUY	$3.77 - $8.67 $39,818 - $91,572	10,562 New	10,562 $89,000

27.1K

150K

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $26.9M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.